Cutaneous manifestations of Proteus syndrome - Correlations with general clinical severity

被引:55
作者
Nguyen, D
Turner, JT
Olsen, C
Bieseckcr, LG
Darling, TN
机构
[1] Uniformed Serv Univ Hlth Sci, Dept Dermatol, Bethesda, MD 20814 USA
[2] Uniformed Serv Univ Hlth Sci, Dept Prevent Med & Biometr, Bethesda, MD 20814 USA
[3] NHGRI, Genet Dis Res Branch, NIH, Bethesda, MD USA
关键词
D O I
10.1001/archderm.140.8.947
中图分类号
R75 [皮肤病学与性病学];
学科分类号
100206 ;
摘要
Background: Proteus syndrome is a rare congenital disorder with progressive asymetric overgrowth of multiple tissues. Objectives: To determine the range of cutaneous findings in Proteus syndrome and to correlate cutaneous findings with overall disease severity. Design: A prospective cohort study was performed at the National Institutes of Health, a tertiary referral center. Patients: Twenty-four consecutive children and adults with Proteus syndrome meeting recent diagnostic criteria. Interventions: Physical examination, including complete skin examination, and review of medical records. Main Outcome Measures: Frequency of skin findings correlation of skin findings with extracutaneous findings; cluster analysis of findings. Results: The 24 patients had skin abnormalities: 22 (92%) had lipomas, 21 (88%) had vascular malformations, 20 (83%) had cerebriform connective tissue nevi on the soles of the feet, 16 (67%) had epidermal nevi, 9 (38%) had partial lipohypoplasia, and 5 (21%) had patchy dermal hypoplasia. Some patients had localized alterations in skin pigmentation and hair or nail growth. Patients with a greater number of skin abnormalities tended to have a greater number of extracutaneous abnormalities. The number of abnormalities tended to increase with age up to 8 years. Conclusions: Patients with Proteus syndrome exhibit a variable but defined assortment of cutaneous findings. The correlation between numbers of cutaneous and extracutaneous abnormalities is consistent with the postulated mosaic basis for this syndrome.
引用
收藏
页码:947 / 953
页数:7
相关论文
共 28 条
[1]   PTEN mutations are uncommon in Proteus syndrome [J].
Barker, K ;
Martinez, A ;
Wang, R ;
Bevan, S ;
Murday, V ;
Shipley, J ;
Houlston, R ;
Harper, J .
JOURNAL OF MEDICAL GENETICS, 2001, 38 (07) :480-481
[2]  
Biesecker LG, 1998, AM J MED GENET, V79, P311, DOI 10.1002/(SICI)1096-8628(19981002)79:4<311::AID-AJMG14>3.0.CO
[3]  
2-U
[4]  
Biesecker LG, 1999, AM J MED GENET, V84, P389, DOI 10.1002/(SICI)1096-8628(19990611)84:5<389::AID-AJMG1>3.0.CO
[5]  
2-O
[6]  
Biesecker LG, 2001, LANCET, V358, P2079, DOI 10.1016/S0140-6736(01)07109-4
[7]   Proteus syndrome:: Misdiagnosis with PTEN mutations [J].
Cohen, MM ;
Turner, JT ;
Biesecker, LG .
AMERICAN JOURNAL OF MEDICAL GENETICS PART A, 2003, 122A (04) :323-324
[8]   Causes of premature death in Proteus syndrome [J].
Cohen, MM .
AMERICAN JOURNAL OF MEDICAL GENETICS, 2001, 101 (01) :1-3
[9]  
COHEN MM, 2002, OVERGROWTH SYNDROMES, P75
[10]  
Gilbert-Barness E, 2000, AM J MED GENET, V93, P234, DOI 10.1002/1096-8628(20000731)93:3<234::AID-AJMG15>3.0.CO